Pharmaron Beijing Co Ltd (300759) — Cash Flow Reinvestment Rate
Pharmaron Beijing Co Ltd (300759) has a Cash Flow Reinvestment Rate of 0.72x as of September 2025, reinvesting CN¥746.35 Million (capex CN¥746.35 Million ) from operating cash flow of CN¥1.04 Billion. Explore Pharmaron Beijing Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharmaron Beijing Co Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for Pharmaron Beijing Co Ltd across 11 annual periods. Also explore 300759 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year capital reinvestment analysis for Pharmaron Beijing Co Ltd. For live market cap and broader valuation context, see Pharmaron Beijing Co Ltd (300759) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.81x | CN¥2.09 Billion | CN¥2.58 Billion | CN¥2.04 Billion | ▼ -56.3% |
| 2023 | 1.86x | CN¥5.12 Billion | CN¥2.75 Billion | CN¥2.87 Billion | ▼ -22.8% |
| 2022 | 2.41x | CN¥5.16 Billion | CN¥2.14 Billion | CN¥2.95 Billion | ▲ +20.5% |
| 2021 | 2.00x | CN¥4.11 Billion | CN¥2.06 Billion | CN¥2.09 Billion | ▲ +27.4% |
| 2020 | 1.57x | CN¥2.59 Billion | CN¥1.65 Billion | CN¥1.32 Billion | ▲ +53.5% |
| 2019 | 1.02x | CN¥959.24 Million | CN¥938.59 Million | CN¥754.61 Million | ▲ +2.2% |
| 2018 | 1.00x | CN¥736.98 Million | CN¥737.26 Million | CN¥640.99 Million | ▼ -46.4% |
| 2017 | 1.87x | CN¥1.03 Billion | CN¥552.22 Million | CN¥934.67 Million | ▼ -79.9% |
| 2016 | 9.31x | CN¥2.19 Billion | CN¥235.77 Million | CN¥1.06 Billion | ▲ +681.7% |
| 2015 | 1.19x | CN¥258.32 Million | CN¥216.94 Million | CN¥258.32 Million | ▼ -82.4% |
| 2014 | 6.75x | CN¥81.94 Million | CN¥12.13 Million | CN¥81.94 Million | — |